Diabetes Publish Ahead of Print published online ahead of print April 24, 2007 DOI: 10.2337/db06-1491
Metabolic endotoxemia initiates obesity and insulin resistance
Patrice D. Cani1,,4,
Jacques Amar2,
Miguel Angel Iglesias1,
Marjorie Poggi3,
Claude Knauf1,
Delphine Bastelica3,
Audrey M. Neyrinck4,
Francesca Fava8,
Kieran M. Tuohy8,
Chantal Chabo1,
Aurélie Waget1,
Evelyne Delmée4,
Béatrice Cousin5,
Thierry Sulpice6,
Bernard Chamontin2,
Jean Ferrières2,
Jean-François Tanti7,
Glenn R. Gibson8,
Louis Casteilla5,
Nathalie M. Delzenne4,
Marie Christine Alessi3, and
Rémy Burcelin1
1 Institute of Molecular Medicine, I2MR U858, IFR 31, Toulouse, France
2 INSERM 558, Toulouse, France
3 INSERM U 626, Marseille, France
4 Unité PMNT-73/69, Université catholique de Louvain, Brussels, Belgium
5 UMR 5241, CNRS, UPS, Toulouse, France
6 Physiogenex S.A.S., Labège innopole, France
7 INSERM U 568, Nice, France
8 Food microbial sciences unit, Department of Food Biosciences, The University of Reading, Reading, UK
Correspondence:
burcelin{at}toulouse.inserm.fr
Diabetes and obesity are two metabolic diseases characterized by insulin resistance and a low grade inflammation. Seeking an inflammatory factor causative of the onset of insulin resistance, obesity, and diabetes, we have identified bacterial lipopolysaccharide (LPS) as a triggering factor. We found that normal endotoxemia increased or decreased during the fed or fasted state respectively on a nutritional basis, and that a four-week high-fat feeding (HF) chronically increased plasma LPS concentration by 2-3 times, a threshold that we have defined as "metabolic endotoxemia". Importantly, HF increased the proportion of a LPS-containing microbiota in the gut. When metabolic endotoxemia was induced for four weeks in mice through continuous subcutaneous infusion of LPS, fasted glycemia, insulinemia, whole body, liver, and adipose tissue weight gain were increased to a similar extent as in HF mice. In addition, adipose tissue F4/80 positive cells and markers of inflammation, and liver triglyceride content, were increased. Furthermore, liver, but not whole body, insulin resistance was detected in LPS-infused mice. CD14 mutant mice resisted most of the LPS and HF-induced features of metabolic diseases. This new finding demonstrates that metabolic endotoxemia dysregulates the inflammatory tone and triggers body weight gain and diabetes. We conclude that the LPS/CD14 system sets the tone of insulin sensitivity, and the onset of diabetes and obesity. Lowering plasma LPS concentration could be a potent strategy for the control of metabolic diseases.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Cabou, G. Campistron, N. Marsollier, C. Leloup, C. Cruciani-Guglielmacci, L. Penicaud, D. J. Drucker, C. Magnan, and R. Burcelin
Brain Glucagon-Like Peptide-1 Regulates Arterial Blood Flow, Heart Rate, and Insulin Sensitivity
Diabetes,
October 1, 2008;
57(10):
2577 - 2587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Rodriguez-Calvo, L. Serrano, T. Coll, N. Moullan, R. M. Sanchez, M. Merlos, X. Palomer, J. C. Laguna, L. Michalik, W. Wahli, et al.
Activation of Peroxisome Proliferator-Activated Receptor {beta}/{delta} Inhibits Lipopolysaccharide-Induced Cytokine Production in Adipocytes by Lowering Nuclear Factor-{kappa}B Activity via Extracellular Signal-Related Kinase 1/2
Diabetes,
August 1, 2008;
57(8):
2149 - 2157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Cani, R. Bibiloni, C. Knauf, A. Waget, A. M. Neyrinck, N. M. Delzenne, and R. Burcelin
Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice
Diabetes,
June 1, 2008;
57(6):
1470 - 1481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, C. Jiang, G. Xu, N. Wang, Y. Zhu, C. Tang, and X. Wang
Homocysteine Upregulates Resistin Production From Adipocytes In Vivo and In Vitro
Diabetes,
April 1, 2008;
57(4):
817 - 827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Saito, H. Hayashida, and R. Furugen
Comment on: Cani et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance: Diabetes 56:1761 1772
Diabetes,
December 1, 2007;
56(12):
e20 - e20.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Burcelin, P. D. Cani, and J. Amar
Response to Comment on: Cani et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance: Diabetes 56:1761 1772
Diabetes,
December 1, 2007;
56(12):
e21 - e21.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cabou, P. D. Cani, G. Campistron, C. Knauf, C. Mathieu, C. Sartori, J. Amar, U. Scherrer, and R. Burcelin
Central Insulin Regulates Heart Rate and Arterial Blood Flow: An Endothelial Nitric Oxide Synthase Dependent Mechanism Altered During Diabetes
Diabetes,
December 1, 2007;
56(12):
2872 - 2877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Erridge, T. Attina, C. M Spickett, and D. J Webb
A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation
Am. J. Clinical Nutrition,
November 1, 2007;
86(5):
1286 - 1292.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Diabetes Association.
|
|
| |
|